Analysed MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ) News Sources
After a 400% Surge, Should Investors Care About This $882,000 Monte Rosa Insider Sale?
29-06-2026
fool.com
Monte Rosa Therapeutics (GLUE) Is Down 30.7% After Deepening Q2 Losses And H1 Earnings Reversal
07-08-2026
yahoo.com
Monte Rosa Therapeutics Announces First Patient Dosed in MODeFIRe-1, a Phase 2 Study of MRT-2359 in Combination with Apalutamide in Patients with AR Mutation-Positive Metastatic Castration-Resistant Prostate Cancer
24-08-2026
yahoo.com
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
08-09-2026
yahoo.com
Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD Risk
01-10-2026
yahoo.com
What is the current price of MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ)?
The current price of MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ) is $10.3.
MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ) absolute price change since previous trading day?
The absolute price change of MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ) since the previous trading day is $-0.02.
MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ) percentage price change since previous trading day?
The percentage price change of MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ) since the previous trading day is -0.1938%.
What is the most recent average sentiment score for MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ)?
The most recent average sentiment score for MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ)?
The most recent sentiment for MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ) is .
SEC-8K** Filing Available For MONTE ROSA THERAPEUTICS INC (GLUE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.